Table 2 Outcome of MH cases. Values are number (proportion)
From: Malignant hyperthermia when dantrolene is not readily available
| Survived | Death | |
|---|---|---|
| total outcome between 1985 and 2010 (n = 61) | 28 (45.9%) | 33 (54.1%) |
| total outcome between 2011 and 2019 (n = 31) | 22 (71.0%) | 9 (29.0%) |
| outcome between 1985 and 2010 without dantrolene (n = 59) | 26 (44.1%) | 33 (55.9%) |
| outcome between 2011 and 2019 without dantrolene (n = 25) | 16 (64.0%) | 9 (36.0%) |